Human clinical trials show mixed, usually modest effects on body composition
Quality varies between suppliers, making verification particularly important
Looking to the next generation of obesity treatments, combinations of GLP-1 with other entero-pancreatic hormones with complementary actions and/or synergistic potential (such as glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin) are under investigation to enhance the WL and cardiometabolic benefits of GLP-1 RA
Semaglutide's effects depend on GLP-1 receptor signaling in the brain and pancreas, while glutathione exerts its effects intracellularly through redox balance
Powered by clinically-studied GLP-1promoting botanicals and prebiotic fibers, it helps extend satiety, steady cravings, and support a healthier metabolic and digestive rhythm throughout the day
Limitations of the Existing Evidence Route mismatch